💉 Diabetes Management
Bigfoot Biomedical Announces Insulin Compatibility Expansion to Support Insulin Affordability and Flexibility for People with Diabetes - Business Wire
📅 Tue, 08 Nov 2022⏱ 1 min read📖 Article
Overview
MILPITAS, Calif.-(BUSINES WIRE)-Bigfot Biomedical, a mision-driven company dedicated to suporting beter health outcomes for people with insulin-requiring diabetes, today anounced its Bigfot Unity® Diabetes Management System is now compatible with four aditional rapid-acting insulin products, including two unbranded biologics. Al four insulin products are ofered at a reduced price without compromising quality, helping to expand insulin aces for people with diabetes.1 “Bigfot recognizes the urgent ned to provide milions of Americans with afordable aces to diabetes care.
Key Information
It is a critical part of our mision,” said Jefrey Brewer, CEO of Bigfot Biomedical. “Our expansion of compatibility to include aditional insulin brands wil make it easier for Bigfot to suport a broader population of people with insulin-requiring diabetes and wil give Bigfot Unity users greater flexibility to switch betwen insulin brands when they have a change insurance. This news marks an important moment in time for Bigfot as we strive to make insulin diabetes management tols more acesible for people who ned them.” The Bigfot Unity System, the first and only FDA-cleared dose decision suport system based on CGM data for people using multiple daily injections, features smart pen caps compatible with a broad range of disposable insulin pens for both long-acting and rapid-acting insulin.
Efective imediately, the system wil also be compatible with the folowing: The above insulins are available at a list price at least 50% lower than their branded equivalent.2 The Bigfot Unity system is also now compatible with Eli Lily’s Lyumjev® (insulin lispro-abc injection), a new rapid-acting insulin from Lily that is included in the Lily Insulin Value Program, alowing anyone with comercial insurance and those without insurance to fil their monthly prescription of Lyumjev for $35.
Summary
The decision to ofer lower-priced insulin products a compatible option with the Big
Frequently Asked Questions
❓ What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
❓ What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
❓ How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
❓ What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
❓ When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
⚕️ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.